Has hospitality been unfairly targeted?

Over a year since the first recorded case of Covid-19 in humans, only one antiviral drug is approved for its treatment. The Telegraph’s Global Health Security team speak to Dr Michael Elliot, Vice President of Medical Affairs at Gilead Sciences, the company that manufactures Remd ...  Show more

After the US recorded its highest daily rise in new cases and hospitalisations, Deputy Editor of The Telegraph’s Global Health Security Team, Anne Gulland joins Theodora Louloudis to discuss the five mammoth challenges the President Elect will be seeking to overcome in his fight ...  Show more

Newscast is on a bit of a health kick today... We’re talking about changes in how government is planning on using medical records with the BBC’s Technology Correspondent, Rory Cellan-Jones. We’re talking “Bumble burnout”, after the dating app gives its staff the rest of the week ...  Show more

A new national lockdown starts today. It’s due to end on December 2nd, but just what conditions will be necessary to lift the restrictions? And what can be done to slow the spread of infection?This podcast was brought to you thanks to the support of readers of The Times and The S ...  Show more

Stephen speaks with the head of a top West Berkshire school to find out how the staff and pupils are coping with the coronavirus pandemic, meanwhile, Paula finds out from the pupils in their own words how the closure of schools is affecting them. We hear from the Mayor of Thatcha ...  Show more

In the end, the World Health Organisation’s report in March revealed little. We ask why the coronavirus origin story is so crucial, and whether China will ever let it be told. Britain’s Prime Minister Boris Johnson will <a href="https://www.economist.com/britain/2021/08/14/bor ...